Clinical trial

Comparison of the Effects of Two Concentrations of Adrenaline (0.33 mg/l vs 1 mg/l) in the Irrigation Serum of Arthroscopic Shoulder Surgery.

Name
2021-A02773-38
Description
The addition of adrenaline to the arthroscopic irrigation serum is used during rotator cuff surgery to limit intraoperative bleeding and ensure a clear view. Two concentrations of adrenaline are commonly used in practice: 1mg/L or 0.33 mg/L. The aim of this study is to determine which of these two doses provides better clarity of the surgical field with less impact on the patient's cardiovascular parameters.
Trial arms
Trial start
2022-06-16
Estimated PCD
2023-06-12
Trial end
2023-06-12
Status
Completed
Treatment
Adrenaline 0,33 Mg/mL Solution for Injection
adrenaline dosage
Arms:
Group 1
Adrenaline 1 Mg/mL Solution for Injection
adrenaline dosage
Arms:
Group 2
Size
181
Primary endpoint
Clarity of the arthroscopic surgical field
Day 1
Eligibility criteria
Inclusion Criteria: * Patient over 18 years of age, having read and signed the consent form for participation in the study after a reflection period (approximately 15 minutes) * Patient with a rotator cuff pathology (subacromial impingement, long biceps tendinopathy or rotator cuff tendinopathy) * Patient for whom an arthroscopic surgical indication has been given Exclusion Criteria: * Allergy to epinephrine * History of Takotsubo cardiomyopathy * Coagulation disorder * Patient under court protection, guardianship or curatorship * Patient not affiliated to the French social security system * Patient participating in another therapeutic protocol * Breastfeeding woman, * Pregnant woman or woman of childbearing age without highly effective contraception for the duration of the study (surgically sterile, intrauterine device (\> 14 days), hormonal contraception (same dose and formulation for at least 6 months), sexual abstinence. Women of childbearing age, i.e. fertile, are considered to be post-menopausal unless they are permanently infertile or have undergone surgical sterilisation. A post-menopausal condition is defined as the absence of menstruation for 12 months without any other medical cause * Patient unable to understand informed information and/or give written informed consent: dementia, psychosis, disturbed consciousness, non-French speaking patient
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Randomised, double-blind, prospective, multicentre study in two parallel groups of 85 patients comparing two concentrations of adrenaline in arthroscopic irrigation fluid (0.33 mg/L vs 1 mg/L', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 181, 'type': 'ACTUAL'}}
Updated at
2024-07-01

1 organization

1 product

Product
Adrenaline